IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
198 hedge funds and large institutions have $795M invested in Impax Laboratories, Inc. in 2016 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
+2
Holders Change %
+1.02%
% of All Funds
4.96%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
39
Increased
72
Reduced
63
Closed
34
Calls
$19K
Puts
$657K
Net Calls
-$638K
Net Calls Change
+$6.28M
Top Buyers
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
$26.5M |
| 2 |
Two Sigma Investments
New York
|
$14.1M |
| 3 |
Renaissance Technologies
New York
|
$14.5M |
| 4 |
Two Sigma Advisers
New York
|
$13.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
$16.7M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$0 |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
$0 |
| 3 |
KAM
Krensavage Asset Management
New York
|
$0 |
| 4 |
HP
Hound Partners
New York
|
$58.8M |
| 5 |
UBS AM
Chicago,
Illinois
|
$204K |